Diana Brixner

3.7k total citations
174 papers, 2.7k citations indexed

About

Diana Brixner is a scholar working on Economics and Econometrics, Endocrinology, Diabetes and Metabolism and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Diana Brixner has authored 174 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Economics and Econometrics, 29 papers in Endocrinology, Diabetes and Metabolism and 21 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Diana Brixner's work include Health Systems, Economic Evaluations, Quality of Life (38 papers), Diabetes Treatment and Management (24 papers) and Diabetes Management and Research (22 papers). Diana Brixner is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (38 papers), Diabetes Treatment and Management (24 papers) and Diabetes Management and Research (22 papers). Diana Brixner collaborates with scholars based in United States, Germany and Austria. Diana Brixner's co-authors include Joseph Biskupiak, Carrie McAdam‐Marx, Gary M. Oderda, Xiangyang Ye, Sameer R. Ghate, A. Keskinaslan, David D. Stenehjem, Sudhir Unni, Sunanda V. Kane and Lisa J. McGarry and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Diabetes.

In The Last Decade

Diana Brixner

166 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Diana Brixner United States 29 497 450 348 329 326 174 2.7k
Anders Sundström Sweden 29 293 0.6× 548 1.2× 416 1.2× 340 1.0× 597 1.8× 70 3.7k
Kristijan H. Kahler United States 27 583 1.2× 454 1.0× 250 0.7× 345 1.0× 480 1.5× 72 2.9k
Wendy L. St. Peter United States 35 370 0.7× 479 1.1× 214 0.6× 262 0.8× 368 1.1× 105 3.7k
P. Ricordeau France 26 276 0.6× 507 1.1× 489 1.4× 332 1.0× 386 1.2× 69 2.4k
Raymond G. Schlienger Switzerland 34 249 0.5× 759 1.7× 507 1.5× 332 1.0× 565 1.7× 81 4.0k
Jason Oke United Kingdom 23 231 0.5× 524 1.2× 498 1.4× 580 1.8× 470 1.4× 94 4.2k
Richard H. Chapman United States 32 1.3k 2.7× 596 1.3× 321 0.9× 488 1.5× 528 1.6× 69 3.9k
Inmaculada Hernandez United States 26 632 1.3× 864 1.9× 258 0.7× 270 0.8× 158 0.5× 147 2.6k
Abdullah Pandor United Kingdom 28 519 1.0× 503 1.1× 311 0.9× 159 0.5× 664 2.0× 81 2.5k
T Walley United Kingdom 31 761 1.5× 383 0.9× 229 0.7× 176 0.5× 387 1.2× 82 3.0k

Countries citing papers authored by Diana Brixner

Since Specialization
Citations

This map shows the geographic impact of Diana Brixner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Brixner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Brixner more than expected).

Fields of papers citing papers by Diana Brixner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Brixner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Brixner. The network helps show where Diana Brixner may publish in the future.

Co-authorship network of co-authors of Diana Brixner

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Brixner. A scholar is included among the top collaborators of Diana Brixner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Brixner. Diana Brixner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brixner, Diana, et al.. (2025). Initial Real-World Evidence for Lecanemab in the United States. Drugs & Aging. 43(1). 69–76.
2.
Ragnhildstveit, Anya, et al.. (2024). SA29 Motivations and Barriers for Psychiatric Practice Adoption of Esketamine Nasal Spray for Treatment-Resistant Depression in the United States. Value in Health. 27(6). S401–S401. 1 indexed citations
3.
Walker, Brandon S., Jennifer Ose, Christopher I. Li, et al.. (2021). Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?. Cancer Epidemiology Biomarkers & Prevention. 30(6). 1106–1113. 2 indexed citations
4.
Stenehjem, David D., Sudhir Unni, Hillevi Bauer, et al.. (2021). BRCA testing and outcomes in women with breast cancer. Breast Cancer Research and Treatment. 186(3). 839–850. 8 indexed citations
5.
Oderda, Gary M., Jacob Eifer Møller, Diana Brixner, et al.. (2021). The patient journey in knee osteoarthritis-variations in diagnosis, patient characteristics, and treatment by physician specialty. Osteoarthritis and Cartilage. 29. S281–S282. 1 indexed citations
6.
Gothe, Holger, Saša Rajšić, Tonio Schoenfelder, et al.. (2019). Algorithms to identify COPD in health systems with and without access to ICD coding: a systematic review. BMC Health Services Research. 19(1). 737–737. 43 indexed citations
7.
Devine, Emily Beth, Eleanor M. Perfetto, A. Simon Pickard, et al.. (2018). Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA Foundation. Publisher.
8.
9.
Brixner, Diana, et al.. (2018). An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets. Value in Health Regional Issues. 16. 9–13. 13 indexed citations
10.
11.
Kachroo, Sumesh, Melissa Hamilton, Xianchen Liu, et al.. (2016). Oral anticoagulant discontinuation in patients with nonvalvular atrial fibrillation.. PubMed. 22(1). e1–8. 31 indexed citations
12.
13.
14.
Rochau, Ursula, Gaby Sroczynski, Dominik Wolf‎, et al.. (2013). Medical decision analysis for first-line therapy of chronic myeloid leukemia. Leukemia & lymphoma. 55(8). 1758–1767. 4 indexed citations
15.
Marcus, Robin L., Diana Brixner, Sameer R. Ghate, & Paul C. LaStayo. (2012). Fat Modulates the Relationship between Sarcopenia and Physical Function in Nonobese Older Adults. Current Gerontology and Geriatrics Research. 2012. 1–6. 17 indexed citations
16.
Kempf, Judy, Erin Buysman, & Diana Brixner. (2011). Health Resource Utilization and Direct Costs Associated with Angina for Patients with Coronary Artery Disease in a US Managed Care Setting.. Europe PMC (PubMed Central). 4(6). 353–61. 24 indexed citations
17.
McAdam‐Marx, Carrie, et al.. (2011). Concurrent Control of Blood Glucose, Body Mass, and Blood Pressure in Patients With Type 2 Diabetes: An Analysis of Data From Electronic Medical Records. Clinical Therapeutics. 33(1). 110–120. 11 indexed citations
18.
19.
Brixner, Diana & Carrie McAdam‐Marx. (2008). Cost-effectiveness of insulin analogs.. PubMed. 14(11). 766–75. 19 indexed citations
20.
Sullivan, Patrick W., Robert J. Valuck, Diana Brixner, & Edward P. Armstrong. (2005). Managed care's response to a pharmacoeconomic model of serotonin reuptake inhibitors. 30(3). 178–181. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anders Sundström Breakdown of academic impact, for papers by Kristijan H. Kahler Breakdown of academic impact, for papers by Wendy L. St. Peter Breakdown of academic impact, for papers by P. Ricordeau Breakdown of academic impact, for papers by Raymond G. Schlienger Breakdown of academic impact, for papers by Jason Oke Breakdown of academic impact, for papers by Richard H. Chapman Breakdown of academic impact, for papers by Inmaculada Hernandez Breakdown of academic impact, for papers by Abdullah Pandor Breakdown of academic impact, for papers by T Walley
Rankless by CCL
2026